Skip to main content

Table 2 Patient Demographics and Symptom Assessment

From: Early gene expression changes with rush immunotherapy

    Skin Test Positivity* Avg. Nasal
SymptomScore**
Patient Age Race Bermuda Ragweed D. Pteryon D.Farinae Baseline 4 mos. Post-RIT
1 56 Caucasian + +    4.0 1.7
2 32 Caucasian + + + + 5.1 2.9
3 28 Indian + + + + 4.0 3.7
  1. * + = greater than or equal to 5 mm on skin prick testing
  2. ** Rhinitis Symptom Severity Score, Range 1 (no symptoms) to 7 (unbearably severe symptoms)